Literature DB >> 16097975

Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.

Adel Aziz1, Christer Bergquist, Mats Brännström, Lena Nordholm, Gunnar Silfverstolpe.   

Abstract

BACKGROUND: Retrospective studies have indicated differences in sexuality and general psychological well-being between women who have undergone hysterectomy only and those undergoing hysterectomy and oophorectomy. These differences may be the result of dissimilarities in the groups of women who choose the respective operation.
OBJECTIVE: To compare the preoperative characteristics of women who choose to undergo prophylactic oophorectomy with the corresponding characteristics of those who choose to retain their ovaries when undergoing hysterectomy on benign indication. POPULATION: Perimenopausal women (aged 45-55), scheduled for hysterectomy on benign indication, were evaluated within 2 months before surgery. A total of 217 women chose hysterectomy only and 106 women chose hysterectomy with concomitant prophylactic oophorectomy.
METHODS: Socioeconomic and health data, personality (Karolinska Scale of Personality), sexuality (McCoy's Female Sexuality Questionnaire), well-being (Psychological General Well-Being index), the prevalence of climacteric symptoms (modified Kupperman's index) and the women's attitude to hormone replacement therapy were investigated.
RESULTS: Women who later underwent prophylactic oophorectomy in addition to hysterectomy had higher anxiety-related scores, lower sexual variable scores and poorer emotional partner relationships. This group was also characterized by more episodes of irregular bleeding, a greater prevalence of climacteric symptoms and a more extensive use of hormonal replacement therapy, in comparison with women who later underwent hysterectomy only.
CONCLUSION: Personality, sexuality and the nature and severity of preoperative symptoms in women who chose prophylactic oophorectomy differ markedly from the same variables in those who chose to keep their ovaries at elective hysterectomy. These differences must be taken into consideration when evaluating studies comparing these aspects of quality of life after hysterectomy or hysterectomy with concomitant oophorectomy. Furthermore, psychosexual aspects such as sexuality and well-being can not be reliably studied with a retrospective design in these patient groups.

Entities:  

Mesh:

Year:  2005        PMID: 16097975     DOI: 10.1111/j.0001-6349.2005.00658.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

Review 1.  Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from?

Authors:  Charlotte A Cornil; Gregory F Ball; Jacques Balthazart
Journal:  Brain Res       Date:  2006-09-15       Impact factor: 3.252

2.  Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions.

Authors:  Vanessa L Jacoby; Eric Vittinghoff; Sanae Nakagawa; Rebecca Jackson; Holly E Richter; John Chan; Miriam Kuppermann
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

3.  Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S).

Authors:  Enzo Grossi; Nicola Groth; Paola Mosconi; Renata Cerutti; Fabio Pace; Angelo Compare; Giovanni Apolone
Journal:  Health Qual Life Outcomes       Date:  2006-11-14       Impact factor: 3.186

4.  Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study.

Authors:  Maria C Cusimano; Maria Chiu; Sarah E Ferguson; Rahim Moineddin; Suriya Aktar; Ning Liu; Nancy N Baxter
Journal:  BMJ       Date:  2021-12-08

5.  Hysterectomies Are Associated with an Increased Risk of Depression: A Population-Based Cohort Study.

Authors:  Tomor Harnod; Weishan Chen; Jen-Hung Wang; Shinn-Zong Lin; Dah-Ching Ding
Journal:  J Clin Med       Date:  2018-10-18       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.